US6470884B2
(en)
|
1996-01-29 |
2002-10-29 |
Aventis Pharma Limited |
Capsule opening arrangement for use in a powder inhaler
|
DE19835346A1
(de)
|
1998-08-05 |
2000-02-10 |
Boehringer Ingelheim Pharma |
Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
|
DE10004465A1
(de)
*
|
2000-02-02 |
2001-08-16 |
Pari Gmbh |
Inhalationsvernebler
|
BR0107304A
(pt)
*
|
2000-10-12 |
2002-08-13 |
Boehringer Ingelheim Pharma |
Pó para inalação contendo tiotrópio
|
US20030070679A1
(en)
*
|
2001-06-01 |
2003-04-17 |
Boehringer Ingelheim Pharma Kg |
Capsules containing inhalable tiotropium
|
US6949154B2
(en)
*
|
2001-07-28 |
2005-09-27 |
Boehringer Ingelheim Pharma Kg |
Method and apparatus for sealing medicinal capsules
|
DE10212264A1
(de)
|
2002-03-20 |
2003-10-02 |
Boehringer Ingelheim Pharma |
Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
|
UA80123C2
(en)
|
2002-04-09 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Inhalation kit comprising inhalable powder of tiotropium
|
US20030235538A1
(en)
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
DE10216429A1
(de)
|
2002-04-12 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
|
ATE349210T1
(de)
|
2002-07-09 |
2007-01-15 |
Boehringer Ingelheim Pharma |
Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
|
DE10230751A1
(de)
|
2002-07-09 |
2004-01-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
|
US7056916B2
(en)
|
2002-11-15 |
2006-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments for the treatment of chronic obstructive pulmonary disease
|
US7763280B2
(en)
|
2002-11-28 |
2010-07-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tiotropium containing powder formulation for inhalation
|
DE10255387A1
(de)
*
|
2002-11-28 |
2004-06-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Tiotropium-haltige Pulverformulierung für die Inhalation
|
DE10258360A1
(de)
*
|
2002-12-12 |
2004-06-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulverinhalator mit Kapselkammer zum Aufnehmen einer mit Wirkstoff gefüllten Einwegkapsel
|
US7284553B2
(en)
|
2002-12-12 |
2007-10-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder inhaler comprising a chamber for a capsule for taking up a non-returnable capsule being filled with an active ingredient
|
US7878193B2
(en)
|
2003-01-14 |
2011-02-01 |
Boehringer Ingelheim International Gmbh |
Capsule for taking an active substance which can be inhaled
|
DE10300982A1
(de)
*
|
2003-01-14 |
2004-07-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulverinhalator
|
US20040173211A1
(en)
*
|
2003-01-14 |
2004-09-09 |
Boehringer Ingelheim International Gmbh |
Powder inhaler
|
DE10300984A1
(de)
*
|
2003-01-14 |
2004-07-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Kapsel zur Aufnahme eines inhalativ applizierbaren Wirkstoffs
|
DE10317461A1
(de)
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
NZ545442A
(en)
|
2003-07-29 |
2010-05-28 |
Boehringer Ingelheim Int |
Medicaments for inhalation comprising betamimetics and an aclidinium salt known as 3-(2-hydroxy-2,2-dithiophen-2-yl-acetoxy)-1-(3-phenoxypropyl)-l-azoniabicyclo[2.2.2]octane
|
EP1506792A3
(en)
*
|
2003-08-14 |
2006-06-07 |
Nathaniel Hughes |
Liquid medicament delivery system
|
US20050042179A1
(en)
*
|
2003-08-18 |
2005-02-24 |
Boehringer Ingelheim International Gmbh |
Inhalative powder formulations containing the CGRP-antagonist 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine
|
EP2083007B1
(de)
|
2003-11-03 |
2013-04-24 |
Boehringer Ingelheim International Gmbh |
Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen
|
CN101407514B
(zh)
|
2003-11-03 |
2013-05-29 |
贝林格尔.英格海姆国际有限公司 |
噻托铵盐、包含噻托铵盐的药物制剂及其用途
|
DE10352277A1
(de)
*
|
2003-11-08 |
2005-06-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulverinhalator
|
EP1718301A1
(en)
*
|
2004-02-20 |
2006-11-08 |
Boehringer Ingelheim International GmbH |
Pharmaceutical compositions based on anticholinergics and pegsunercept
|
US20050272726A1
(en)
*
|
2004-04-22 |
2005-12-08 |
Boehringer Ingelheim International Gmbh |
Novel medicaments for the treatment of respiratory diseases
|
CA2559699C
(en)
|
2004-04-22 |
2012-06-19 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
|
US7611709B2
(en)
|
2004-05-10 |
2009-11-03 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
|
US7723306B2
(en)
|
2004-05-10 |
2010-05-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
|
US7727962B2
(en)
|
2004-05-10 |
2010-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
GB0410712D0
(en)
*
|
2004-05-13 |
2004-06-16 |
Novartis Ag |
Organic compounds
|
DE102004024451A1
(de)
|
2004-05-14 |
2005-12-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten
|
US20050256115A1
(en)
*
|
2004-05-14 |
2005-11-17 |
Boehringer Ingelheim International Gmbh |
Aerosol formulation for the inhalation of beta-agonists
|
US20050255050A1
(en)
*
|
2004-05-14 |
2005-11-17 |
Boehringer Ingelheim International Gmbh |
Powder formulations for inhalation, comprising enantiomerically pure beta agonists
|
US7220742B2
(en)
|
2004-05-14 |
2007-05-22 |
Boehringer Ingelheim International Gmbh |
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
DE602005019604D1
(de)
|
2004-11-10 |
2010-04-08 |
Cipla Ltd |
Inhalator
|
US8758816B2
(en)
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
MX2007006233A
(es)
|
2004-11-24 |
2007-11-23 |
Medpointe Healthcare Inc |
Composiciones que comprenden azelastina y metodos de uso de la misma.
|
US20070020330A1
(en)
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
DE102005001332A1
(de)
|
2005-01-11 |
2006-07-20 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
|
US7694676B2
(en)
*
|
2005-04-22 |
2010-04-13 |
Boehringer Ingelheim Gmbh |
Dry powder inhaler
|
DK1881980T3
(da)
|
2005-05-02 |
2012-10-01 |
Boehringer Ingelheim Int |
Nye krystalline former af tiotropiumbromid
|
DE102005022862A1
(de)
*
|
2005-05-18 |
2006-12-14 |
Airsec S.A.S |
Kapseln für Inhalatoren
|
EP1898894A1
(en)
*
|
2005-06-17 |
2008-03-19 |
Boehringer Ingelheim International GmbH |
Mrp iv inhibitors for the treatment of respiratory diseases
|
DE102005030733A1
(de)
|
2005-07-01 |
2007-01-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
|
CN101208316B
(zh)
|
2005-08-15 |
2012-05-09 |
贝林格尔·英格海姆国际有限公司 |
制备β-模拟物的方法
|
TWI396541B
(zh)
|
2005-10-10 |
2013-05-21 |
Boehringer Ingelheim Int |
用於治療呼吸疾病之新穎藥物組合
|
DE102006009637A1
(de)
*
|
2005-10-28 |
2007-05-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator mit Mundstück mit mikrobiologischer Schutzfunktion
|
US7423146B2
(en)
|
2005-11-09 |
2008-09-09 |
Boehringer Ingelheim International Gmbh |
Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
|
DE102005054383B4
(de)
*
|
2005-11-15 |
2013-10-31 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Nadel zum Lochen von Pulverkapseln für die Inhalation
|
DE102005059602A1
(de)
|
2005-12-14 |
2007-06-21 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Mikronisierung
|
DE102006016901A1
(de)
|
2006-04-11 |
2007-10-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Mundstück für einen Inhalator
|
DE102006016903A1
(de)
|
2006-04-11 |
2007-10-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
DE102006016904A1
(de)
|
2006-04-11 |
2007-10-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
DE102006017699A1
(de)
|
2006-04-15 |
2007-10-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
EP2051714B1
(de)
|
2006-08-07 |
2011-04-13 |
Boehringer Ingelheim International GmbH |
Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
|
UY30550A1
(es)
|
2006-08-22 |
2008-03-31 |
Boehringer Ingelheim Int |
Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
|
EP1925295A1
(de)
|
2006-11-22 |
2008-05-28 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Stabile Pulverformulierung enthaltend ein Anticholinergikum
|
DE102007036411A1
(de)
|
2007-07-20 |
2009-02-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulverinhalator
|
DE102007033860A1
(de)
|
2007-07-20 |
2009-01-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Prüfvorrichtung
|
DE102007033861A1
(de)
|
2007-07-20 |
2009-07-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulverinhalator
|
EP2020249A1
(de)
|
2007-08-01 |
2009-02-04 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Inhalator
|
DE102007052871A1
(de)
|
2007-11-02 |
2009-05-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Kapsel zur Aufnahme von pharmazeutischen Wirkstoffformulierungen
|
US8637239B2
(en)
|
2007-11-05 |
2014-01-28 |
The Board Of Trustees Of The University Of Illinois |
Minimally-invasive measurement of esophageal inflammation
|
DK2082769T3
(en)
|
2008-01-24 |
2015-08-31 |
Vectura Delivery Devices Ltd |
inhaler
|
WO2009103336A1
(de)
*
|
2008-02-20 |
2009-08-27 |
Boehringer Ingelheim International Gmbh |
Pulverinhalatoren
|
EP2093219A1
(de)
|
2008-02-22 |
2009-08-26 |
Boehringer Ingelheim International Gmbh |
Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
|
DE202008015493U1
(de)
|
2008-11-21 |
2009-02-12 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Faltschachtel
|
AT507631B1
(de)
*
|
2008-11-26 |
2012-05-15 |
Haas Rouven Mag |
Vorrichtung zum ansaugen von pulver- oder granulat-material und kapsel hierfür
|
US20120129820A1
(en)
|
2009-02-09 |
2012-05-24 |
Boehringer Ingelheim International Gmbh |
New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
EP2451787B1
(en)
|
2009-07-06 |
2013-04-24 |
Boehringer Ingelheim International GmbH |
Polymorph of [4,6-bis(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)pyrimidin-5-yl]
|
US8746244B2
(en)
|
2009-10-02 |
2014-06-10 |
Boehringer Ingelheim International Gmbh |
Powder inhaler
|
EP2504318A2
(en)
|
2009-11-24 |
2012-10-03 |
Boehringer Ingelheim International GmbH |
Crystalline salt forms of a pyrimidin-5-yl acetic acid derivative
|
MX2012006003A
(es)
|
2009-11-24 |
2012-06-19 |
Boehringer Ingelheim Int |
Procedimiento para preparar un polimorfo de la sal de colina de [4,6-bis(dimetilamino)-2-(4-{[4-(trifluorometil)-benzoil]amino}be ncil)pirimidin-5-ilo].
|
TR200909788A2
(tr)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
|
JP5415341B2
(ja)
*
|
2010-03-31 |
2014-02-12 |
株式会社吉野工業所 |
粉体吸入デバイス
|
JP5431240B2
(ja)
*
|
2010-04-27 |
2014-03-05 |
株式会社吉野工業所 |
粉体吸入デバイス
|
FR2962338B1
(fr)
*
|
2010-07-07 |
2012-08-03 |
Valois Sas |
Inhalateur de poudre seche.
|
FR2962337B1
(fr)
*
|
2010-07-07 |
2013-02-15 |
Valois Sas |
Inhalateur de poudre seche.
|
RU2013105007A
(ru)
*
|
2010-07-07 |
2014-08-20 |
Аптар Франс Сас |
Способ применения ингалятора сухого порошка
|
FR2962339B1
(fr)
*
|
2010-07-07 |
2013-02-15 |
Valois Sas |
Inhalateur de poudre seche.
|
GB201020638D0
(en)
*
|
2010-12-06 |
2011-01-19 |
Liconsa Laboratorios Sa |
Inhalator
|
FR2968566B1
(fr)
*
|
2010-12-14 |
2013-10-18 |
Valois Sas |
Inhalateur de poudre seche.
|
DE102011107858A1
(de)
|
2011-07-01 |
2013-01-03 |
Khs Gmbh |
Gassperre sowie Füllelement mit wenigstens einer Gassperre
|
WO2013016784A1
(en)
|
2011-08-04 |
2013-02-07 |
Victor Esteve |
Dry powder inhaler
|
JP6284884B2
(ja)
|
2011-11-25 |
2018-02-28 |
ビルギチ,マフムト |
吸入装置
|
US9248247B2
(en)
|
2012-07-26 |
2016-02-02 |
Nathaniel Gerald Portney |
Capsular medication delivery and inhalation device
|
EP2705838A1
(en)
|
2012-09-06 |
2014-03-12 |
Xspray Microparticles Ab |
Tiotropium preparations
|
BR112015031590B1
(pt)
|
2013-07-16 |
2021-05-18 |
Victor Esteve |
inalador de pó
|
US10292687B2
(en)
*
|
2014-08-15 |
2019-05-21 |
Covidien Lp |
Designs and methods to facilitate swallowing of a tethered cell collection device
|
EP3061501A1
(en)
|
2015-02-27 |
2016-08-31 |
Rottapharm Ltd. |
Composition for the treatment of acne
|
DE102015108931B3
(de)
*
|
2015-06-05 |
2016-06-09 |
Gerresheimer Regensburg Gmbh |
Gitterelement für einen Inhalator
|
DE102015109996B3
(de)
|
2015-06-22 |
2016-07-28 |
Gerresheimer Regensburg Gmbh |
Einrichtung zum Öffnen von Kapseln
|
EP3117825A1
(en)
|
2015-07-16 |
2017-01-18 |
Rottapharm S.p.A. |
Oral formulation comprising berberine and morus alba extract
|
PL3284499T3
(pl)
*
|
2016-08-15 |
2019-11-29 |
Tiefenbacher Alfred E Gmbh & Co Kg |
Inhalator suchego proszku z odtwarzalnym oporem przepływu
|
PL3645090T3
(pl)
*
|
2017-10-24 |
2021-05-31 |
Merxin Ltd |
Inhalator
|
CN109821118A
(zh)
|
2017-11-23 |
2019-05-31 |
正大天晴药业集团股份有限公司 |
新型肺部药物输送***
|
CN111542308B
(zh)
*
|
2017-12-13 |
2024-04-02 |
埃姆弗西斯进出口及分销有限公司 |
干粉吸入器
|